GSK will use supercomputers to develop new drugs
It has signed a $43 million deal with a deep learning company called Exscientia.
Google teams up with GSK to develop 'bioelectronic medicines'
Galvani Bioelectronics' first project will look into the treatment of type 2 diabetes.
Apple entices its first big drug company to ResearchKit
The PARADE study will focus on 300 patients suffering with rheumatoid arthritis.